doi: 10.1038/s41586-020-2222-z 62 WeinandKSakaueSNathanAJonssonAHZhangFWattsGFMet al
Conclusion and Future Perspectives Weight loss, while beneficial for reducing cardiometabolic risk, is consistently associated with adverse effects on skeletal health
Real-world evidence indicates that many individuals undergoing GLP-1 pills therapy report significant reductions in cravings, enabling them to navigate their dietary choices with greater ease
L., & Jialal, I
Grauslund, J., Abou Taha, A., Dehghani Molander, L., Kawasaki, R., Mller, S., Hjlund, K., & Stokholm, L., Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes, International Journal of Retina and Vitreous , accepted for publication
Regular medical supervision ensures that doses are well tolerated and adjusted for each patients needs